KIORA PHARMACEUTICALS, INC. (KPRX) Operating cash flow 2016–2025
KIORA PHARMACEUTICALS, INC. (KPRX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$10.0MFY2025 · since FY2016: -$8.4M → -$10.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$10.0M | -216.4% |
| FY2024 | $8.6M | +189.6% |
| FY2023 | -$9.6M | +8.4% |
| FY2022 | -$10.4M | +2.3% |
| FY2021 | -$10.7M | -45.9% |
| FY2020 | -$7.3M | +10.3% |
| FY2019 | -$8.2M | +24.8% |
| FY2018 | -$10.8M | -67.7% |
| FY2017 | -$6.5M | +23.1% |
| FY2016 | -$8.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice